Hepatotoxicity and Drug-Induced Liver Injury

Hepatotoxicity occurs when toxins or drugs cause liver damage, which can lead to liver failure or chronic liver disease. Drug-induced liver injury (DILI) is a leading cause of liver transplantation. Research focuses on identifying early biomarkers, understanding metabolic pathways that contribute to toxicity, and developing safer pharmaceuticals. Improved preclinical screening and personalized medicine approaches help predict which patients are at higher risk for DILI, improving the safety of new drugs and treatments.

    Related Conference of Hepatotoxicity and Drug-Induced Liver Injury

    October 29-30, 2026

    14th International Conference on Green Energy

    Paris, France
    November 19-20, 2026

    15th World Conference on Earth Science & Geology

    Dubai, UAE
    December 08-09, 2026

    21st World Convention on Waste Recycling and Reuse

    Paris, France
    January 20-21, 2027

    14th Global Summit and Expo on Pollution Control

    Paris, France
    June 21-22, 2027

    12th Global Summit on Climate Change

    Paris, France

    Hepatotoxicity and Drug-Induced Liver Injury Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in